The two pathways converge, resulting in the activation of transcription factors (e.g., NF-κB) that coordinate the production of inflammatory mediators and the activation of various leukocyte genes, creating a cancer-related inflammatory microenvironment [36]. The gene discussed is NFKB1; the disease is cancer.